PROGRAMS

Proven Programs. Professional Management.

Following the Arizona Heart Institute model, Arizona Heart International Ltd. will offer the following clinical programs. AZHI will also install and manage a variety of value-added service programs to differentiate our facilities throughout the market. Additionally, many of these programs help build solid local, regional and international connections in the name of cutting edge medicine and optimum patient care.

AZHI Clinical Programs will include:

Complete Diagnostics
▪ Blood Lab
▪ Electrocardiography (ECG)
▪ 64 Slice CT
▪ Nuclear Medicine
▪ Ultrasound

Peripheral Vascular
▪ Vein Therapy
▪ Carotid Stenting
▪ Endovascular Repair of Aneurysmal Disease
▪ Balloon Angioplasty
▪ Atherectomy

Cardiovascular Surgery
▪ Bypass Graft
▪ Pacemakers
▪ Valve Surgery
▪ Laser TMR

Interventional Cardiology
▪ Balloon Angioplasty and Stenting
▪ Valvuloplasty
▪ Laser Recanalization
▪ Atherectomy

AHI Physician Immersion Program

Physicians recruited for AZHI facilities will participate in the prestigious AHI physician immersion program where they will work side-by-side with some of the world’s leading CVD specialists at the Arizona Heart Institute main campus in Phoenix, Arizona, USA. As part of the daily operations in one of the world’s most progressive cardiovascular campus, each participant will receive first-hand knowledge of the procedures and protocols that can be applied to their home cardiovascular care facility.

Virtual Consults and Second Opinions

Through strategic alliances with various technology providers, AZHI will design and operate a state-of-the-art audio/video link between our US and international facilities. This communications link will offer international physicians with direct access to some of the world’s top cardiovascular specialists for real-time consultations.

Community Outreach and Education

Facilities dedicated to prevention will make an impact by helping the general public learn healthy behaviors, early warning signs and risk factors associated with CVD. This will promote early detection of the disease to offer patients more treatment options.